The anti-inflammatory baricitinib is normally used to treat rheumatoid arthritis.
Trials suggest it can cut death risk by about a fifth in patients needing hospital care for severe Covid. BBC News
See also:
- Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis (open access preprint) medRxiv
- New RECOVERY trial result: baricitinib reduces deaths in patients hospitalised with COVID-19 RECOVERY
- UK's daily Covid cases rise again: Infections jump 17% in a week to 45,656 The Daily Mail
- UK Covid deaths plunge after all restrictions abandoned – but infections are creeping back up The Independent
- COVID tests must remain free and self-isolation rules shouldn't be ditched, NHS leaders warn Sky News
No comments:
Post a Comment